Adam Morgan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Alpharetta, GA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Adam Morgan
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Adam Morgan

Form 4 holding Director

HERON THERAPEUTICS, INC. /DE/

Security class
Stock Option (Right to Buy)
Shares / value
35,900
Estimated value
$62,107
Report date
31 Jan 2025
Price
$1.73
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ALIMERA SCIENCES INC

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
16 Sep 2024
Price
$3.83
Ownership
By Velan Capital Master Fund LP
Form 4 holding Director, 10%+ Owner

ALIMERA SCIENCES INC

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
16 Sep 2024
Price
$3.83
Ownership
By Velan Capital SPV I LLC
Form 4 holding Director

HERON THERAPEUTICS, INC. /DE/

Security class
Series A Convertible Preferred Stock
Shares / value
70,012
Estimated value
Report date
08 Aug 2025
Price
Ownership
By Velan Capital Master Fund LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ALIMERA SCIENCES INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
16 Sep 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ALIMERA SCIENCES INC

Security class
Warrants
Shares / value
0
Estimated value
Report date
16 Sep 2024
Price
Ownership
By Velan Capital Master Fund LP
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Adam Morgan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .